Antiviral therapy during compensated cirrhosis most cost-effective approach
Thursday, May 27, 2010 - 11:21
in Health & Medicine
Researchers found that antiviral therapy during compensated cirrhosis, when compared with all other strategies, is the most cost-effective approach to treating patients with advanced liver disease due to hepatitis C (HCV) infection.